A Comparative Analysis of Testosterone Therapy and Phosphodiesterase 5 Inhibitor Monotherapy and Combined Therapy in Men with Erectile Dysfunction and Low Testosterone Levels.

A retrospective chart review of 50 men with low testosterone levels treated for erectile dysfunction with testosterone therapy, phosphodiesterase-5 inhibitor, alone or both in combination, was conducted at a community urology practice. Clinically improved responses were found with combination therap...

Descripción completa

Detalles Bibliográficos
Publicado en:Urologic Nursing Vol. 40; no. 1; pp. 11 - 22
Autor principal: Julien, David
Formato: CEU research tables/charts Journal Article
Publicado: Society of Urologic Nurses & Associates, Inc. Jan/Feb2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141657305&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 141657305
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1053816X
        4TZ
      jtl: Urologic Nursing
      issn: 1053816X
      maglogo: N
    pubinfo:
      dt: Jan/Feb2020
      vid: 40
      iid: 1
      pid: 6437
      pub: Society of Urologic Nurses & Associates, Inc.
      place: Pitman, New Jersey
    artinfo:
      ui:
        141657305
        141657305
        141657305
        10.7257/1053-816X.2020.40.1.11
        141657305
      ppf: 11
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: A Comparative Analysis of Testosterone Therapy and Phosphodiesterase 5 Inhibitor Monotherapy and Combined Therapy in Men with Erectile Dysfunction and Low Testosterone Levels.
      aug:
        au: Julien, David
        affil: Associate Professor, University at Buffalo, School of Nursing, Buffalo, NY
      sug:
        subj:
          Testosterone Replacement Therapy
          Phosphodiesterase Inhibitors Therapeutic Use
          Erectile Dysfunction Drug Therapy
          Testosterone Blood
          Drug Therapy, Combination
          Human
          Pilot Studies
          Male
          Men's Health
          Adult
          Middle Age
          Aged
          Retrospective Design
          Record Review
          Convenience Sample
          Descriptive Statistics
          Data Analysis Software
          Chi Square Test
          Analysis of Variance
          Treatment Outcomes
          Education, Continuing (Credit)
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
      ab: A retrospective chart review of 50 men with low testosterone levels treated for erectile dysfunction with testosterone therapy, phosphodiesterase-5 inhibitor, alone or both in combination, was conducted at a community urology practice. Clinically improved responses were found with combination therapy.
      pubtype: Academic Journal
      doctype:
        CEU
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N